Abstract: Feline AIDS and Feline Leukemia, or FIV and FeLV, respectively are important non-zoonotic inmunosupressing diseases in veterinary medicine which affect domestic and wild felines. However, in Ecuador, there is minimal effort for control and epidemiological survey. The main objective of this investigation is to determine the epidemiological situation and risk factors, from these diseases, based on data from the teaching veterinary hospital “Hospital Docente de Especialidades Veterinarias” of the Universidad San Francisco de Quito, and from the veterinary laboratory, LabVet. Aside from obtaining serological results from both the hospital and the lab, within a 3 and 5 year timeframe, respectively, an additional survey was used to register the presenting clinical signs and lifestyles of the cats that came into the hospital, during a 4 month timeframe. The lab has shown an average of 5.89% prevalence for FeLV and 0.94% for FIV; meanwhile, hospital prevalence for FeLV was 9.11% and 0.45% for FIV. Out of the 41 cats attended at the hospital, only 7 confirmed cases of FeLV were registered during the timeframe, while there weren’t any FIV cases, limiting the identification of risk factors and clinical sign frequency of it. With a 95% confidence, cachexia and vomiting were highly attributed to being infected by FeLV. In the same matter, it was confirmed that neutered cats have a lesser risk of being infected by this disease. However, the results were not very reliable. Also, it was not possible to make any relationship between sex, breed and outdoor access due the insufficient data. In conclusion, FeLV has a notable presence in Quito, but more research is needed to obtain more reliable results. ; El SIDA y la Leucemia Viral Felina, o VIF y ViLeF, respectivamente, son enfermedades inmunosupresoras, no zoonóticas, de gran importancia en medicina veterinaria, que afecta a felinos domésticos y silvestres. Sin embargo, en el Ecuador, existen limitados esfuerzos por su control y vigilancia epidemiológica. El principal objetivo ...
No Comments.